Peregrine Pharma (PPHM) Posts Q1 Loss of $0.14, Misses Views
Tweet Send to a FriendGet Alerts PPHM Hot Sheet
Price: $1.54 +1.99%
Revenue Growth %: -100.0%
Financial Fact:
License revenue: 78K
Today's EPS Names:
LBIX, ESEA, ISS, More
Revenue Growth %: -100.0%
Financial Fact:
License revenue: 78K
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade PPHM Now!
Peregrine Pharmaceuticals (Nasdaq: PPHM) reports Q1 loss of $0.14, versus the analyst estimate of ($0.11). Revenue for the quarter was $3.21 million, which compares to the estimate of $5.83 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Wal-mart (WMT) Posts Q1 EPS of $1.14; U.S. Comps Down 1.4%; Guides Q2 EPS
- Notable Winners and Losers from Q1 Earnings Season: (YRCW) (TSLA) (AVEO) (CRMB)
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
